The studies utilized postsynaptic density protein (PSD)-95 antibody (1:1,000, molecular weight of 95 kDa, Cell Signaling, Danvers, MA) to detect PSD-95 level. An β-Actin antibody (1:5,000, molecular weight of 42 kDa, Sigma, St. Louis, MO) was used to detect non-targeted protein β-Actin. The quantification of Western-blot was accomplished as described in other studies 49. In brief, we analyzed the signal intensity via Quantity One image analysis program (Bio-Rad, Hercules, CA). Two steps were used to quantify the Western blots. At the first step, β-Actin was used to standardize protein amounts (e.g., calculating the ratio of PSD-95 in relation to β-Actin amount) and limit the differences in the protein amount loaded. At the second step, we expressed the protein levels obtained from the treatment as a % in relation to control condition.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.